Citations (210)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Ruyi Shao, Yeben Wang, Laifeng Li, Yongqiang Dong, Jiayi Zhao & Wenqing Liang. (2022) Bone tumors effective therapy through functionalized hydrogels: current developments and future expectations. Drug Delivery 29:1, pages 1631-1647.
Read now
Read now
Han Zhang, Guanhong Chen, Xiajie Lyu, Chun Rong, Yingzhen Wang, Ying Xu & Chengyu Lyu. (2021) A Novel Predictive Model Associated with Osteosarcoma Metastasis. Cancer Management and Research 13, pages 8411-8423.
Read now
Read now
Tianhua Yu, Dexin Chen, Lei Zhang & Daqian Wan. (2019) microRNA-26a-5p Promotes Proliferation and Migration of Osteosarcoma Cells by Targeting HOXA5 in vitro and in vivo. OncoTargets and Therapy 12, pages 11555-11565.
Read now
Read now
Zhong Wu, Junjian Liu & Fan Zhang. (2017) Interleukin-6 upregulates SOX18 expression in osteosarcoma. OncoTargets and Therapy 10, pages 5329-5336.
Read now
Read now
Yu-Sheng Li, Zhen-Han Deng, Chao Zeng & Guang-Hua Lei. (2016) JNK pathway in osteosarcoma: pathogenesis and therapeutics. Journal of Receptors and Signal Transduction 36:5, pages 465-470.
Read now
Read now
Li Wang, Minhong Shan, Yang Liu, Fengyi Yang, Hongxia Qi, Lijuan Zhou, Lirong Qiu & Yanshuang Li. (2015) miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA. OncoTargets and Therapy 8, pages 2635-2642.
Read now
Read now
Ning-Kui Niu, Zi-Li Wang, Shu-Ting Pan, Hui-Qiang Ding, Giang HT Au, Zhi-Xu He, Zhi-Wei Zhou, Guozhi Xiao, Yin-Xue Yang, Xueji Zhang, Tianxin Yang, Xiao-Wu Chen, Jia-Xuan Qiu & Shu-Feng Zhou. (2015) Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Drug Design, Development and Therapy 9, pages 1555-1584.
Read now
Read now
Zhong Wu, Shaohua Li, Jie Liu, Yongzhen Shi, Jianguang Wang, Dong Chen, Linjie Luo, Yongqiang Qian, Xiang Huang & Hua Wang. (2015) RNAi-mediated silencing of AQP1 expression inhibited the proliferation, invasion and tumorigenesis of osteosarcoma cells. Cancer Biology & Therapy 16:9, pages 1332-1340.
Read now
Read now
Isabel Correia, Regina Arantes-Rodrigues, Rosário Pinto-Leite & Isabel Gaivão. (2014) Effects of Naproxen on Cell Proliferation and Genotoxicity in MG-63 Osteosarcoma Cell Line. Journal of Toxicology and Environmental Health, Part A 77:14-16, pages 916-923.
Read now
Read now
Ellen Niederberger & Gerd Geisslinger. (2013) Proteomics and NF-κB: an update. Expert Review of Proteomics 10:2, pages 189-204.
Read now
Read now
Jessica Lee Yarber & Mark Agulnik. (2011) Targeted therapies in bone sarcomas: current approach and future directions. Expert Opinion on Investigational Drugs 20:7, pages 973-979.
Read now
Read now
Colin Kong & Marc F Hansen. (2009) Biomarkers in osteosarcoma. Expert Opinion on Medical Diagnostics 3:1, pages 13-23.
Read now
Read now
Xudong Liu, Bingfang Zeng, Jie Ma & Chunling Wan. (2009) Comparative Proteomic Analysis of Osteosarcoma Cell and Human Primary Cultured Osteoblastic Cell. Cancer Investigation 27:3, pages 345-352.
Read now
Read now
German A Marulanda, Eric R Henderson, Brian T Palumbo, Gerald E Alexander, David Cheong & G Douglas Letson. (2008) Use of extendable prostheses: a limb-salvaging alternative for patients with malignant bone tumors. Expert Review of Medical Devices 5:4, pages 467-474.
Read now
Read now
Articles from other publishers (196)
Kexin Li, Xun Sun, Hudie Li, Hailan Ma, Meng Zhou, Kazumasa Minami, Keisuke Tamari, Kazuhiko Ogawa, Pankita H. Pandya, M. Reza Saadatzadeh, Melissa A. Kacena, Karen E. Pollok, Bai-Yan Li & Hiroki Yokota. (2023) Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes. Genes & Diseases 10:4, pages 1641-1656.
Crossref
Crossref
DeLayna Goulding, Lauren Arguinchona, Amy Anderson-Mellies, Margit Mikkelsen, Megan Eguchi, Hannah Marinoff, Shadi Zahedi, Karina Braga Ribeiro, Myles Cockburn, Carlos Rodriguez Galindo & Adam L. Green. (2023) Sociodemographic Disparities in Presentation and Survival of Pediatric Bone Cancers. Journal of Pediatric Hematology/Oncology 45:1, pages e31-e43.
Crossref
Crossref
Jiaxun Song, Xiaofeng Yuan, Lianhua Piao, Jiawen Wang, Pu Wang, Ming Zhuang, Jie Liu & Zhiwei Liu. (2022) Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma. Frontiers in Oncology 12.
Crossref
Crossref
Todd Hudson, Connor Burke, Donna Mullner & Fernando A. Herrera. (2022) Risk factors associated with 30‐day complications following lower extremity sarcoma surgery: A national surgical quality improvement project analysis. Journal of Surgical Oncology 126:7, pages 1253-1262.
Crossref
Crossref
Felix Bläsius, Heide Delbrück, Frank Hildebrand & Ulf Krister Hofmann. (2022) Surgical Treatment of Bone Sarcoma. Cancers 14:11, pages 2694.
Crossref
Crossref
Xiaoli He, Yongkang Liao, Jing Liu & Shuming Sun. (2022) Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation. Molecules 27:7, pages 2128.
Crossref
Crossref
Christina Enciso Holm, Michala Skovlund Soerensen, Müjgan Yilmaz & Michael Mørk Petersen. (2022) Evaluation of tumor-prostheses over time: Complications, functional outcome, and comparative statistical analysis after resection and reconstruction in orthopedic oncologic conditions in the lower extremities. SAGE Open Medicine 10, pages 205031212210941.
Crossref
Crossref
Salah-Eddine Lamhamedi-Cherradi, Sana Mohiuddin, Dhruva K. Mishra, Sandhya Krishnan, Alejandra Ruiz Velasco, Amelia M. Vetter, Kristi Pence, David McCall, Danh D. Truong, Branko Cuglievan, Brian A. Menegaz, Budi Utama, Najat C. Daw, Eric R. Molina, Rafal J. Zielinski, John A. Livingston, Richard Gorlick, Antonios G. Mikos, Min P. Kim & Joseph A. Ludwig. (2021) Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma. Cancer Gene Therapy 28:12, pages 1325-1338.
Crossref
Crossref
Shoulei Liang, Yong Li & Baocang Wang. (2021) The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma. International Journal of Clinical Oncology 26:12, pages 2347-2354.
Crossref
Crossref
Assaf Zinger, Gherardo Baudo, Tomoyuki Naoi, Federica Giordano, Stefania Lenna, Matteo Massaro, April Ewing, Ha Ram Kim, Ennio Tasciotti, Jason T. Yustein & Francesca Taraballi. (2020) Reproducible and Characterized Method for Ponatinib Encapsulation into Biomimetic Lipid Nanoparticles as a Platform for Multi-Tyrosine Kinase-Targeted Therapy. ACS Applied Bio Materials 3:10, pages 6737-6745.
Crossref
Crossref
Henrietta O. Fasanya & Dietmar W. Siemann. (2020) The Role of Cathepsins in the Growth of Primary and Secondary Neoplasia in the Bone. Osteology 1:1, pages 3-28.
Crossref
Crossref
Yang Jiao, Yimin Guo, Yingcong Fan, Rui Wang, Xiang Li, Hao Wu, Zhichao Meng, Xin Yang, Yunpeng Cui, Heng Liu, Liping Pan, Talatibaike Maimaitijuma, Jiazhen Zhang, Yahong Wang, Yongping Cao & Tao Zhang. (2020) Triggering of Apoptosis in Osteosarcoma 143B Cell Line by Carbon Quantum Dots via the Mitochondrial Apoptotic Signal Pathway. BioMed Research International 2020, pages 1-12.
Crossref
Crossref
Samer Abdel Al, Ahmad M. Shehadeh, Mohamad K. Abou Chaar, Wafa Asha, Nijmeh Alsaadi, Hani Al-Najjar & Hussam Haddad. (2020) Surgical Reconstruction Methods following Radical Excision of Distal Ulna Osteosarcoma in Both Skeletally Mature and Immature Patients. Case Reports in Oncology 13:2, pages 558-568.
Crossref
Crossref
Raquel Sánchez‐Céspedes, Paolo Accornero, Silvia Miretti, Eugenio Martignani, Francesca Gattino, Lorella Maniscalco, Cecilia Gola, Selina Iussich, Marina Martano, Emanuela Morello, Paolo Buracco, Luca Aresu & Raffaella De Maria. (2019) In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models. Veterinary and Comparative Oncology 18:1, pages 117-127.
Crossref
Crossref
Kathryn E. Gallaway, Junho Ahn & Alexandra K. Callan. (2020) Thirty-Day Outcomes after Surgery for Primary Sarcomas of the Extremities: An Analysis of the NSQIP Database. Journal of Oncology 2020, pages 1-8.
Crossref
Crossref
Emily L. Chen, Christopher H. Yoo, Paulina M. Gutkin, David J. Merriott, Raffi S. Avedian, Robert J. Steffner, Sheri L. Spunt, Allison K. Pribnow, Lynn Million, Sarah S. Donaldson & Susan M. Hiniker. (2019) Outcomes for pediatric patients with osteosarcoma treated with palliative radiotherapy. Pediatric Blood & Cancer 67:1.
Crossref
Crossref
I. V. Zhilkin, D. G. Akhaladze, D. V. Litvinov, N. G. Uskova, M. V. Tihonova, N. S. Grachev & A. I. Karachunskiy. (2019) Osteosarcoma with lung metastases. Pediatric Hematology/Oncology and Immunopathology 18:4, pages 127-135.
Crossref
Crossref
Abul Arif, Marc F. Hansen, Cynthia B. Alander, David K. Monson, Nickolas B. Reimer & Hicham Drissi. (2019) Cancer Stem Cells and Osteosarcoma: Opportunities and Limitations. Techniques in Orthopaedics 34:4, pages 275-286.
Crossref
Crossref
Joo Tae Hwang, Ki-Sun Park, Jin Ah Ryuk, Hye Jin Kim & Byoung Seob Ko. (2019) Development of an Oriental Medicine Discrimination Method through Analysis of Steroidal Saponins in Dioscorea nipponica Makino and Their Anti-Osteosarcoma Effects. Molecules 24:22, pages 4022.
Crossref
Crossref
Weijia Zhao, Zonghan Chen & Meng Guan. (2019) Polydatin enhances the chemosensitivity of osteosarcoma cells to paclitaxel. Journal of Cellular Biochemistry 120:10, pages 17481-17490.
Crossref
Crossref
Sana Iram, Manaal Zahera, Iram Wahid, Abu Baker, Mohammad Raish, Altaf Khan, Naushad Ali, Saheem Ahmad & Mohd Sajid Khan. (2019) Cisplatin bioconjugated enzymatic GNPs amplify the effect of cisplatin with acquiescence. Scientific Reports 9:1.
Crossref
Crossref
Yizhe Xi, Mitra Fowdur, Yun Liu, Hao Wu, Maolin He & Jinmin Zhao. (2019) Differential expression and bioinformatics analysis of circRNA in osteosarcoma. Bioscience Reports 39:5.
Crossref
Crossref
Yu-sheng Li, Qing Liu, Jian Tian, Hong-bo He & Wei Luo. (2019) Angiogenesis Process in Osteosarcoma: An Updated Perspective of Pathophysiology and Therapeutics. The American Journal of the Medical Sciences 357:4, pages 280-288.
Crossref
Crossref
Sama Izadpanah, Parastoo Shabani, Ali Aghebati-Maleki, Elham Baghbani, Amir Baghbanzadeh, Ali Fotouhi, Babak Bakhshinejad, Leili Aghebati-Maleki & Behzad Baradaran. (2019) Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy. Biomedicine & Pharmacotherapy 111, pages 873-881.
Crossref
Crossref
Mehdi Nikkhah, Maryam Ghasemi, Rostam Poormoosa, Somayeh Sheidaei & Mozhdeh Akbari. (2019) Osteosarcoma misdiagnosed as cholesteatoma. Indian Journal of Otology 25:3, pages 166.
Crossref
Crossref
Dabiao Liu & Xuesong Liu. (2018) Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy. Medicine 97:49, pages e13358.
Crossref
Crossref
T.T. Pierce, R. Shailam, S. Lozano-Calderon & P. Sagar. (2018) Inter-rater Variability in the Interpretation of Pre and Post Contrast MRI for Pre-Surgical Evaluation of Osteosarcoma in Long Bones in Pediatric Patients and Young Adults. Surgical Oncology.
Crossref
Crossref
Shuwei Zhang, Yi Wang, Shuzhen Chen & Jingfeng Li. (2018) Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells. Biomedicine & Pharmacotherapy 106, pages 1396-1403.
Crossref
Crossref
Guang‑Yu Du, Sheng‑Wei He, Lu Zhang, Chuan‑Xiu Sun, Li‑Dong Mi & Zue‑Gang Sun. (2018) Hesperidin exhibits in�vitro and in�vivo antitumor effects in human osteosarcoma MG‑63 cells and xenograft mice models via inhibition of cell migration and invasion, cell cycle arrest and induction of mitochondrial‑mediated apoptosis. Oncology Letters.
Crossref
Crossref
Xing Bao, Libo Zhao, Hanfeng Guan & Feng Li. (2018) Inhibition of LCMR1 and ATG12 by demethylation-activated miR-570-3p is involved in the anti-metastasis effects of metformin on human osteosarcoma. Cell Death & Disease 9:6.
Crossref
Crossref
Neng Ru, Fan Zhang, Jie Liang, Yuanli Du, Weifei Wu, Feifan Wang & Xinzong Liu. (2018) MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt. Gene 645, pages 163-169.
Crossref
Crossref
Yanjie Guo, Jimin Yin, Mingjie Tang & Xingang Yu. (2018) Downregulation of SOX3 leads to the inhibition of the proliferation, migration and invasion of osteosarcoma cells. International Journal of Oncology.
Crossref
Crossref
Rajendra Kumar, Meena Kumar, Kavin Malhotra & Shreyaskumar Patel. (2018) Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment. Current Oncology Reports 20:2.
Crossref
Crossref
Zhe Jiang, Chunshan Jiang & Jinnv Fang. (2018) Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway. Biochemical and Biophysical Research Communications 495:1, pages 238-245.
Crossref
Crossref
Qingbo Li, Xiaohan Pan, Xiqian Wang, Xiejia Jiao, Jiachun Zheng, Zhiqiang Li & Yanqing Huo. (2017) Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma. Oncotarget 8:63, pages 106648-106660.
Crossref
Crossref
Fei Zhang & Hao Peng. (2017) LncRNA-ANCR regulates the cell growth of osteosarcoma by interacting with EZH2 and affecting the expression of p21 and p27. Journal of Orthopaedic Surgery and Research 12:1.
Crossref
Crossref
Hao Zhang, Guangchao Wang, Chen Ding, Peng Liu, Renkai Wang, Wenbin Ding, Dake Tong, Dajiang Wu, Cheng Li, Qiang Wei, Xin Zhang, Di Li, Peizhao Liu, Haochen Cui, Hao Tang & Fang Ji. (2017) Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression. Oncotarget 8:37, pages 61687-61697.
Crossref
Crossref
Yinghua Sun, Fuchao Wang, Li Wang, Zhaode Jiao, Jun Fang & Jianmin Li. (2017) MicroRNA-433 regulates apoptosis by targeting PDCD4 in human osteosarcoma cells. Oncology Letters 14:2, pages 2353-2358.
Crossref
Crossref
Po-Hao Chen, David A. Mankoff & Ronnie A. Sebro. (2017) Clinical overview of the current state and future applications of positron emission tomography in bone and soft tissue sarcoma. Clinical and Translational Imaging 5:4, pages 343-358.
Crossref
Crossref
Bingpeng Chen, Jingjing Liu, Ji Qu, Yang Song, Yuxiang Li & Su Pan. (2017) MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4. Tumor Biology 39:7, pages 101042831770384.
Crossref
Crossref
Qian Zhou, Miao Xian, Senfeng Xiang, Danyan Xiang, Xuejing Shao, Jincheng Wang, Ji Cao, Xiaochun Yang, Bo Yang, Meidan Ying & Qiaojun He. (2017) All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages. Cancer Immunology Research 5:7, pages 547-559.
Crossref
Crossref
Loes Lambrecht, Charlotte Sleurs, Veerle Labarque, Catharina Dhooge, Annouschka Laenen, Friedl Sinnaeve, Marleen Renard & Anne Uyttebroeck. (2017)
The role of the
MTHFR
C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients
. Pharmacogenomics 18:8, pages 787-795.
Crossref
Crossref
Suraj Pratap, Hanumantha R. Pokala, William H. Meyer, Bradley C. Gehrs & Maria F. Palacios. (2017) Diffuse Marrow Involvement in Metastatic Osteosarcoma: An Unusual Presentation. Journal of Oncology Practice 13:6, pages 401-403.
Crossref
Crossref
Chunhong Liu, Mingming Ma, Junde Zhang, Shaoliu Gui, Xiaohai Zhang & Shuangtao Xue. (2017) Galangin inhibits human osteosarcoma cells growth by inducing transforming growth factor-β1-dependent osteogenic differentiation. Biomedicine & Pharmacotherapy 89, pages 1415-1421.
Crossref
Crossref
Sayantan Ray, Suman Saha, Biswanath Sa & Jui Chakraborty. (2017) In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma. Drug Delivery and Translational Research 7:2, pages 259-275.
Crossref
Crossref
Gaia Palmini, Francesca Marini & Maria Brandi. (2017) What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?. Molecules 22:3, pages 417.
Crossref
Crossref
Hsuan-Kan Chang & Jau-Ching Wu. 2017. Lateral Access Minimally Invasive Spine Surgery. Lateral Access Minimally Invasive Spine Surgery
201
214
.
Shuai Li, Yong Gao, Yan Wang, Kun Wang, Zhi-Peng Dai, Dong Xu, Wei Liu, Zhi-Liang Li, Zheng-Dong Zhang, Shu-Hua Yang & Cao Yang. (2016) Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma. Oncology Letters 12:6, pages 4905-4910.
Crossref
Crossref
Cristina Municio, Blanca Soler Palacios, Lizbeth Estrada-Capetillo, Alberto Benguria, Ana Dopazo, Elena García-Lorenzo, Salvador Fernández-Arroyo, Jorge Joven, María Eugenia Miranda-Carús, Isidoro González-Álvaro & Amaya Puig-Kröger. (2016) Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis. Annals of the Rheumatic Diseases 75:12, pages 2157-2165.
Crossref
Crossref
Guoxiang Wang, Zhengyao zhang, Maoguang Yang, Bo Xu, Qi gao & Xiaoyu Yang. (2016) Comparative proteomics analysis of human osteosarcoma by 2D DIGE with MALDI-TOF/TOF MS. Journal of Bone Oncology 5:4, pages 147-152.
Crossref
Crossref
Liang Wang, Hongwei Gao, Ningji Gong & Mingzhi Gong. (2016) Downregulation of microRNA‑497 is associated with upregulation of synuclein�γ in patients with osteosarcoma. Experimental and Therapeutic Medicine.
Crossref
Crossref
Di Yang, Hirohiko Okamura, Hiroyuki Morimoto, Jumpei Teramachi & Tatsuji Haneji. (2016) Protein phosphatase 2A Cα regulates proliferation, migration, and metastasis of osteosarcoma cells. Laboratory Investigation 96:10, pages 1050-1062.
Crossref
Crossref
Chusong Zhou, Wei Tan, Hai Lv, Fei Gao & Jin Sun. (2016) Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma. Cellular Oncology 39:5, pages 463-471.
Crossref
Crossref
Guang Wan, Jin‑Gang Tao, Guo‑Dong Wang, Shen‑Peng Liu, Hong‑Xing Zhao & Qiu‑Dong Liang. (2016) In�vitro antitumor activity of the ethyl acetate extract of Potentilla chinensis in osteosarcoma cancer cells. Molecular Medicine Reports.
Crossref
Crossref
Riccardo Di Fiore, Rosa Drago-Ferrante, Francesca Pentimalli, Domenico Di Marzo, Iris Maria Forte, Daniela Carlisi, Anna De Blasio, Giovanni Tesoriere, Antonio Giordano & Renza Vento. (2016) Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells. Journal of Cellular Physiology 231:8, pages 1832-1841.
Crossref
Crossref
Dong Dong, Yubao Gong, Debao Zhang, Huricha Bao & Guishan Gu. (2015) miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3. Tumor Biology 37:5, pages 6447-6455.
Crossref
Crossref
Lin Li, Shoulei Liang, Amanda R. Wasylishen, Yanqin Zhang, Xueli Yang, Bingzheng Zhou, Luling Shan, Xiuxin Han, Tianyang Mu, Guowen Wang & Shunbin Xiong. (2016) PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway. Oncotarget 7:14, pages 18021-18035.
Crossref
Crossref
Tomohiro Fujiwara & Toshifumi Ozaki. (2016) Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells. Stem Cells International 2016, pages 1-13.
Crossref
Crossref
Zaijun Lin, Dianwen Song, Haifeng Wei, Xinghai Yang, Tielong Liu, Wangjun Yan & Jianru Xiao. (2015) TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma. Journal of Cancer Research and Clinical Oncology 142:1, pages 239-246.
Crossref
Crossref
Hui Zhou, Minglei Zhang, Hongping Yuan, Wei Zheng, Chunyan Meng & Dongxu Zhao. (2015) MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a. Oncology Reports.
Crossref
Crossref
E Estrada-Villaseor, R Escamilla-Uribe, P De la Garza-Montano, R Dominguez-Rubio, V Martinez-Lopez, A Avila-Luna, A Alfaro-Rodriguez, EK Ruvalcaba-Paredes, D Garciadiego-Cazares & C Bandala. (2015) Association of Metastasis with Clinicopathological Data in Mexican Patients with Osteosarcoma, Giant Cell Tumor of Bone and Chondrosarcoma. Asian Pacific Journal of Cancer Prevention 16:17, pages 7689-7694.
Crossref
Crossref
Xiu-guo Han, Lin Du, Han Qiao, Bing Tu, Yu-gang Wang, An Qin, Ke-rong Dai, Qi-ming Fan & Ting-ting Tang. (2015) CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin. Cancer Letters 369:2, pages 405-415.
Crossref
Crossref
Zhong Wu, Junjian Liu, Jianguang Wang & Fan Zhang. (2015) SOX18 knockdown suppresses the proliferation and metastasis, and induces the apoptosis of osteosarcoma cells. Molecular Medicine Reports.
Crossref
Crossref
Cara Cipriano, Lauren Brockman, Jason Romancik, Robert Hartemayer, Jeffrey Ording, Curt Ginder, Joel Krier, Steven Gitelis & Paul Kent. (2015) The Clinical Significance of Initial Pulmonary Micronodules in Young Sarcoma Patients. Journal of Pediatric Hematology/Oncology 37:7, pages 548-553.
Crossref
Crossref
XIAOFENG LIU, LIUBING LI, LING LV, DONGMEI CHEN, LIQIN SHEN & ZONGGANG XIE. (2015) Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/β-catenin signaling pathway. Oncology Reports 34:2, pages 1035-1041.
Crossref
Crossref
Dawei Yang, Peng Wang & Xiaoping Ren. (2015) Apoptosis induced by chamaejasmine in human osteosarcoma cells through p53 pathway. Tumor Biology 36:7, pages 5433-5439.
Crossref
Crossref
Le Chang, Vi Nguyen, Alan Nguyen, Michelle A. Scott & Aaron W. James. (2015) Pericytes in sarcomas of bone. Medical Oncology 32:7.
Crossref
Crossref
Yao Lu, Bin Hu, Guo-Feng Guan, Jie Chen, Chun-qiu Wang, Qiong Ma, Yan-Hua Wen, Xiu-Chun Qiu, Xiao-ping Zhang & Yong Zhou. (2015) SDF-1/CXCR4 promotes F5M2 osteosarcoma cell migration by activating the Wnt/β-catenin signaling pathway. Medical Oncology 32:7.
Crossref
Crossref
LIN WANG, HONG-SHENG HE, HUA-LONG YU, YUN ZENG, HENG HAN, NING HE, ZHI-GANG LIU, ZHI-YONG WANG, SHOU-JIA XU & MIN XIONG. (2015) Sclareol, a plant diterpene, exhibits potent antiproliferative effects via the induction of apoptosis and mitochondrial membrane potential loss in osteosarcoma cancer cells. Molecular Medicine Reports 11:6, pages 4273-4278.
Crossref
Crossref
Le Chang, Swati Shrestha, Greg LaChaud, Michelle A. Scott & Aaron W. James. (2015) Review of microRNA in osteosarcoma and chondrosarcoma. Medical Oncology 32:6.
Crossref
Crossref
Shoulei Liang, Zhiwu Ren, Xiuxin Han, Jilong Yang, Luling Shan, Lin Li, Binying Wang, Qianyi Zhang, Tianyang Mu, Kexin Chen, Shunbin Xiong & Guowen Wang. (2015) PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis. PLOS ONE 10:5, pages e0127236.
Crossref
Crossref
Surabhi Parashar, David Cheishvili, Ani Arakelian, Zahid Hussain, Imrana Tanvir, Haseeb Ahmed Khan, Moshe Szyf & Shafaat A. Rabbani. (2015)
S
‐adenosylmethionine blocks osteosarcoma cells proliferation and invasion
in vitro
and tumor metastasis
in vivo
: therapeutic and diagnostic clinical applications
. Cancer Medicine 4:5, pages 732-744.
Crossref
Crossref
Yaxia Zhang, Andrew E. Rosenberg, Lester J. Layfield & G. Petur Nielsen. 2015. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology
1008
1124
.
Fuwu Zhang, Shiyi Zhang, Stephanie F. Pollack, Richen Li, Amelia M. Gonzalez, Jingwei Fan, Jiong Zou, Sarah E. Leininger, Adriana Pavía-Sanders, Rachel Johnson, Laura D. Nelson, Jeffery E. Raymond, Mahmoud Elsabahy, Dennis M. P. Hughes, Mark W. Lenox, Tiffany P. Gustafson & Karen L. Wooley. (2015)
Improving Paclitaxel Delivery:
In Vitro
and
In Vivo
Characterization of PEGylated Polyphosphoester-Based Nanocarriers
. Journal of the American Chemical Society 137:5, pages 2056-2066.
Crossref
Crossref
Yu-sheng Li, Zhen-han Deng, Chao Zeng & Guang-hua Lei. (2014) Role of osteopontin in osteosarcoma. Medical Oncology 32:1.
Crossref
Crossref
Wenxi Yu, Lina Tang, Feng Lin, Yang Yao & Zan Shen. (2014) Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: Does the analog matter?. Medical Oncology 32:1.
Crossref
Crossref
Joeri Both, Oscar Krijgsman, Johannes Bras, Gerard R. Schaap, Frank Baas, Bauke Ylstra & Theo J. M. Hulsebos. (2014) Focal Chromosomal Copy Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma. PLoS ONE 9:12, pages e115835.
Crossref
Crossref
Lei Wang, Fangchun Jin, An Qin, Yongqiang Hao, Yufeng Dong, Shengfang Ge & Kerong Dai. (2014) Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase family. Molecular Cancer 13:1.
Crossref
Crossref
Teruki Kidani, Atsushi Nakamura, Setsuya Kamei, Yoshiaki Norimatsu, Hiromasa Miura & Hiroshi Masuno. (2014) Overexpression of cytoplasmic β-catenin inhibits the metastasis of the murine osteosarcoma cell line LM8. Cancer Cell International 14:1.
Crossref
Crossref
Kailiang Zhang, Yinglong Zhang, Kun Ren, Guangyi Zhao, Kang Yan & Baoan Ma. (2014) MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression. Oncology Reports.
Crossref
Crossref
Osama M. Al-Quteimat & Mariam A. Al-Badaineh. (2014) Practical issues with high dose methotrexate therapy. Saudi Pharmaceutical Journal 22:4, pages 385-387.
Crossref
Crossref
Ye Tian, Ying-Ze Zhang & Wei Chen. (2014) MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells. Bioscience Reports 34:4.
Crossref
Crossref
HUIGUANG YANG, YUNQING ZHANG, ZHENGMING ZHOU, XUEFENG JIANG & AIDONG SHEN. (2014) Transcription factor Snai1-1 induces osteosarcoma invasion and metastasis by inhibiting E-cadherin expression. Oncology Letters 8:1, pages 193-197.
Crossref
Crossref
Ning Zhang, Mei-Dan Ying, Yong-Ping Wu, Zhi-Hong Zhou, Zhao-Ming Ye, Hang Li & Ding-Sheng Lin. (2014) Hyperoside, a Flavonoid Compound, Inhibits Proliferation and Stimulates Osteogenic Differentiation of Human Osteosarcoma Cells. PLoS ONE 9:7, pages e98973.
Crossref
Crossref
Chaoyin Jiang, Hua Chen, Lei Shao & Qiaojie Wang. (2014) MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31. Oncology Reports.
Crossref
Crossref
Jian-Hua Yi, Dong Wang, Zhi-Yong Li, Jun Hu, Xiao-Feng Niu & Xiao-Lin Liu. (2014) C-Reactive Protein as a Prognostic Factor for Human Osteosarcoma: A Meta-Analysis and Literature Review. PLoS ONE 9:5, pages e94632.
Crossref
Crossref
Zhang Ye, Li Jingzhong, Liu Yangbo, Chen Lei & Yuan Jiandong. (2014) Propofol Inhibits Proliferation and Invasion of Osteosarcoma Cells by Regulation of MicroRNA-143 Expression. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 21:4, pages 201-207.
Crossref
Crossref
Keisuke Shimbo, Shigeru Miyaki, Hiroyuki Ishitobi, Yoshio Kato, Tadahiko Kubo, Shoji Shimose & Mitsuo Ochi. (2014) Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochemical and Biophysical Research Communications 445:2, pages 381-387.
Crossref
Crossref
P.M. Anderson, P. Meyers, E. Kleinerman, K. Venkatakrishnan, D.P. Hughes, C. Herzog, W. Huh, R. Sutphin, Y.M. Vyas, V. Shen, A. Warwick, N. Yeager, C. Oliva, B. Wang, Y. Liu & A. Chou. (2013) Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments. Pediatric Blood & Cancer 61:2, pages 238-244.
Crossref
Crossref
Marcelo F. Cipreste & Edesia M. B. Sousa. (2014) Poly(Vinyl Alcohol)/Collagen/Hydroxyapatite Nanoparticles Hybrid System Containing Yttrium-90 as a Potential Agent to Treat Osteosarcoma. Journal of Biomaterials and Nanobiotechnology 05:01, pages 24-30.
Crossref
Crossref
Tomohiro Fujiwara, Ryou-u Takahashi, Nobuyoshi Kosaka, Yutaka Nezu, Akira Kawai, Toshifumi Ozaki & Takahiro Ochiya. (2014) RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis. Molecular Therapy - Nucleic Acids 3, pages e189.
Crossref
Crossref
Drew D. Moore & Hue H. Luu. 2014. Orthopaedic Oncology. Orthopaedic Oncology
65
92
.
Xia Zhang, Anindita Sarangi, Dai-Tze Wu, Jaya Kanduri & Monica J Roth. (2013) Gene delivery in a mouse xenograft of a retargeted retrovirus to a solid 143B osteosarcoma. Virology Journal 10:1.
Crossref
Crossref
Sukhvinder Johal, Stephen Ralston & Christopher Knight. (2013) Mifamurtide for High-Grade, Resectable, Nonmetastatic Osteosarcoma Following Surgical Resection: A Cost-Effectiveness Analysis. Value in Health 16:8, pages 1123-1132.
Crossref
Crossref
Guoqiong Yang, Jian Yuan & Kanghua Li. (2013) EMT transcription factors: implication in osteosarcoma. Medical Oncology 30:4.
Crossref
Crossref
Hwan Cho. (2013) Capsaicin induces apoptosis in MG63 human osteosarcoma cells via the caspase cascade and the antioxidant enzyme system. Molecular Medicine Reports.
Crossref
Crossref
Alexandra K Abrams, Raffi S Avedian & Neyssa Marina. (2013) Treating pediatric osteosarcoma: recent clinical trial evidence. Clinical Investigation 3:10, pages 967-978.
Crossref
Crossref
Risa Harada, Teruya Kawamoto, Takeshi Ueha, Masaya Minoda, Mitsunori Toda, Yasuo Onishi, Naomasa Fukase, Hitomi Hara, Yoshitada Sakai, Masahiko Miwa, Ryosuke Kuroda, Masahiro Kurosaka & Toshihiro Akisue. (2013) Reoxygenation using a novel CO2 therapy decreases the metastatic potential of osteosarcoma cells. Experimental Cell Research 319:13, pages 1988-1997.
Crossref
Crossref
Jinglei Miao, Song Wu, Zhi Peng, Mousumi Tania & Chaoyue Zhang. (2013) MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumor Biology 34:4, pages 2093-2098.
Crossref
Crossref
Jung Kim. (2013) The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells. Oncology Reports.
Crossref
Crossref
Aina He, Weixiang Qi, Yujing Huang, Yuanjue Sun, Zan Shen, Hui Zhao, Yumei Yang & Yang Yao. (2012) Comparison of pirarubicin-based versus gemcitabine–docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience. International Journal of Clinical Oncology 18:3, pages 498-505.
Crossref
Crossref
Jun-qiang Yin, Lili Wen, Liang-cai Wu, Zhen-hua Gao, Gang Huang, Jin Wang, Chang-ye Zou, Ping-xian Tan, Bi-cheng Yong, Qiang Jia & Jing-nan Shen. (2013) The glycogen synthase kinase-3β/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells. Toxicology Letters 218:2, pages 129-136.
Crossref
Crossref
Jonathan Moses, Neil Gibson, Thomas Plesec, Gregory Plautz, Marsha Kay & Oliver Soldes. (2013) Metastatic osteosarcoma to the stomach and ascending colon in a pediatric patient causing gastrointestinal hemorrhage. Journal of Pediatric Surgery 48:4, pages e1-e3.
Crossref
Crossref
Tomohiro Fujiwara, Akira Kawai, Akihiko Yoshida, Toshifumi Ozaki & Takahiro Ochiya. 2013. Role of Cancer Stem Cells in Cancer Biology and Therapy. Role of Cancer Stem Cells in Cancer Biology and Therapy
23
78
.
Daliu Min, Feng Lin, Zan Shen, Shuier Zheng, Lina Tan, Wenxi Yu & Yang Yao. (2013) Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy. Asia-Pacific Journal of Clinical Oncology 9:1, pages 71-79.
Crossref
Crossref
Atsushi Nakamura, Junichi Aizawa, Kenshi Sakayama, Teruki Kidani, Tomoyo Takata, Yoshiaki Norimatsu, Hiromasa Miura & Hiroshi Masuno. (2012) Genistein inhibits cell invasion and motility by inducing cell differentiation in murine osteosarcoma cell line LM8. BMC Cell Biology 13:1.
Crossref
Crossref
A N Rettew, E D Young, D C Lev, E S Kleinerman, F W Abdul-Karim, P J Getty & E M Greenfield. (2012) Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines. Oncogenesis 1:11, pages e34-e34.
Crossref
Crossref
Bo Wang, Liming Fang, Hui Zhao, Tong Xiang & Dechun Wang. (2012) MDM2 inhibitor Nutlin-3a suppresses proliferation and promotes apoptosis in osteosarcoma cells. Acta Biochimica et Biophysica Sinica 44:8, pages 685-691.
Crossref
Crossref
Aidong Shen, Yunqing Zhang, Huiguang Yang, Ruisheng Xu & Guowei Huang. (2011) Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma. Journal of Surgical Oncology 105:8, pages 830-834.
Crossref
Crossref
Edwin Choy, Francis Hornicek, Laura MacConaill, David Harmon, Zeeshan Tariq, Levi Garraway & Zhenfeng Duan. (2011) High‐throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide‐3‐kinase and other oncogenes. Cancer 118:11, pages 2905-2914.
Crossref
Crossref
KEN KATAOKA, TOMOYUKI ONO, HITOSHI MURATA, MIKA MORISHITA, KEN-ICHI YAMAMOTO, MASAKIYO SAKAGUCHI & NAM-HO HUH. (2012) S100A7 promotes the migration and invasion of osteosarcoma cells via the receptor for advanced glycation end products. Oncology Letters 3:5, pages 1149-1153.
Crossref
Crossref
Eisuke Kobayashi, Francis J. Hornicek & Zhenfeng Duan. (2012) MicroRNA Involvement in Osteosarcoma. Sarcoma 2012, pages 1-8.
Crossref
Crossref
Laila Holmboe, Anders M. Andersen, Lars Mørkrid, Lars Slørdal & Kirsten Sundby Hall. (2012) High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients. British Journal of Clinical Pharmacology 73:1, pages 106-114.
Crossref
Crossref
Patrick C. Hsieh & Alexander Taghva. 2012. Tumors of the Central Nervous System, Volume 6. Tumors of the Central Nervous System, Volume 6
221
232
.
Åsa M Johansson, Nicola Hill, Martha Perisoglou, Jeremy Whelan, Mats O Karlsson & Joseph F Standing. (2011) A Population Pharmacokinetic/Pharmacodynamic Model of Methotrexate and Mucositis Scores in Osteosarcoma. Therapeutic Drug Monitoring 33:6, pages 711-718.
Crossref
Crossref
Huiguang Yang, Yunqing Zhang, Zhengming Zhou, Xuefeng Jiang & Aidong Shen. (2011) Snail-1 regulates VDR signaling and inhibits 1,25(OH)-D3 action in osteosarcoma. European Journal of Pharmacology 670:2-3, pages 341-346.
Crossref
Crossref
Mitsuhiko Osaki, Fumitaka Takeshita, Yui Sugimoto, Nobuyoshi Kosaka, Yusuke Yamamoto, Yusuke Yoshioka, Eisuke Kobayashi, Tesshi Yamada, Akira Kawai, Toshiaki Inoue, Hisao Ito, Mitsuo Oshimura & Takahiro Ochiya. (2011) MicroRNA-143 Regulates Human Osteosarcoma Metastasis by Regulating Matrix Metalloprotease-13 Expression. Molecular Therapy 19:6, pages 1123-1130.
Crossref
Crossref
Xing Dai, Wei Ma, Xijing He & Rajiv Kumar Jha. (2011) Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing’s sarcoma. Medical Science Monitor 17:8, pages RA177-RA190.
Crossref
Crossref
Soojung Hong, Sang Joon Shin, Minkyu Jung, Jaeheon Jeong, Young Joo Lee, Kyoo-Ho Shin, Jae Kyung Roh & Sun Young Rha. (2011) Comparison of Long-Term Outcome between Doublet and Triplet Neoadjuvant Chemotherapy in Non-Metastatic Osteosarcoma of the Extremity. Oncology 80:1-2, pages 107-117.
Crossref
Crossref
Krithi Rao-Bindal & Eugenie S. Kleinerman. (2011) Epigenetic Regulation of Apoptosis and Cell Cycle in Osteosarcoma. Sarcoma 2011, pages 1-5.
Crossref
Crossref
Patrick Hseih & Ziya L. Gokaslan. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery
3144
3153
.
Xiang Hu, Ai-Xi Yu, Bai-Wen Qi, Tao Fu, Gang Wu, Min Zhou, Jun Luo & Jun-Hua Xu. (2010) The expression and significance of IDH1 and p53 in osteosarcoma. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
Crossref
Junichi Aizawa, Kenshi Sakayama, Setsuya Kamei, Teruki Kidani, Haruyasu Yamamoto, Yoshiaki Norimatsu & Hiroshi Masuno. (2010) Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8. BMC Cancer 10:1.
Crossref
Crossref
Xiao-zhong Zhu, Hong-mei Yin & Jiong Mei. (2010) Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy. Acta Pharmacologica Sinica 31:8, pages 970-976.
Crossref
Crossref
Sarah E. Kelly, Altomare Di Benedetto, Adelaide Greco, Candace M. Howard, Vincent E. Sollars, Donald A. Primerano, Jagan V. Valluri & Pier Paolo Claudio. (2010) Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications. PLoS ONE 5:4, pages e10035.
Crossref
Crossref
Y. Li, Q. Liang, Y-q. Wen, L-l. Chen, L-t. Wang, Y-l. Liu, C-q. Luo, H-z. Liang, M-t. Li & Z. Li. (2010) Comparative proteomics analysis of human osteosarcomas and benign tumor of bone. Cancer Genetics and Cytogenetics 198:2, pages 97-106.
Crossref
Crossref
Eisuke Kobayashi, Mari Masuda, Robert Nakayama, Hitoshi Ichikawa, Reiko Satow, Miki Shitashige, Kazufumi Honda, Umio Yamaguchi, Ayako Shoji, Naobumi Tochigi, Hideo Morioka, Yoshiaki Toyama, Setsuo Hirohashi, Akira Kawai & Tesshi Yamada. (2010) Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma. Molecular Cancer Therapeutics 9:3, pages 535-544.
Crossref
Crossref
Tuan-Min Yang, Shi-Fang Guo, Chang-Rui Chen, Xiao-Yu Zhang & Wen-Guang Li. (2008)
Anti-osteosarcoma effects and mechanisms of 4-
O
-amino-phenol-4‘-demethylepipodophyllotoxin ether
. Journal of Pharmacy and Pharmacology 60:2, pages 179-188.
Crossref
Crossref
Angela E. Ellis, Barry G. Harmon, Debra L. Miller, Nicole C. Northrup, Kenneth S. Latimer & Elizabeth W. Uhl. (2010) Gingival Osteogenic Melanoma in Two Dogs. Journal of Veterinary Diagnostic Investigation 22:1, pages 147-151.
Crossref
Crossref
Marc F. Hansen. 2009. Bone and Cancer. Bone and Cancer
19
42
.
Patrick C. Hsieh, Khan W. Li, Daniel M. Sciubba, Ian Suk, Jean-Paul Wolinsky & Ziya L. Gokaslan. (2009) POSTERIOR-ONLY APPROACH FOR TOTAL EN BLOC SPONDYLECTOMY FOR MALIGNANT PRIMARY SPINAL NEOPLASMS. Operative Neurosurgery 65:6, pages ons173-ons181.
Crossref
Crossref
Hang T. Ta, Crispin R. Dass, Ian Larson, Peter F.M. Choong & Dave E. Dunstan. (2009) A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy. Biomaterials 30:27, pages 4815-4823.
Crossref
Crossref
Dennis PM Hughes. (2009) Novel agents in development for pediatric sarcomas. Current Opinion in Oncology 21:4, pages 332-337.
Crossref
Crossref
Hang T. Ta, Crispin R. Dass, Ian Larson, Peter F.M. Choong & Dave E. Dunstan. (2009) A chitosan–dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma. Biomaterials 30:21, pages 3605-3613.
Crossref
Crossref
Setsuya Kamei, Kenshi Sakayama, Shinta Tamashiro, Junichi Aizawa, Joji Miyawaki, Tatsuhiko Miyazaki, Haruyasu Yamamoto, Yoshiaki Norimatsu & Hiroshi Masuno. (2008) Ketoprofen in topical formulation decreases the matrix metalloproteinase‐2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma. Journal of Orthopaedic Research 27:7, pages 909-915.
Crossref
Crossref
O. Kenneth Macdonald & Christopher M. Lee. (2009) Radiotherapy for Primary and Metastatic Spinal Tumors. Seminars in Spine Surgery 21:2, pages 121-128.
Crossref
Crossref
Hang T. Ta, Crispin R. Dass, Peter F. M. Choong & Dave E. Dunstan. (2009) Osteosarcoma treatment: state of the art. Cancer and Metastasis Reviews 28:1-2, pages 247-263.
Crossref
Crossref
Myke R. Green & Marc C. Chamberlain. (2008) Renal dysfunction during and after high-dose methotrexate. Cancer Chemotherapy and Pharmacology 63:4, pages 599-604.
Crossref
Crossref
Christopher B. Weldon, Megan E. Anderson, Mark C. Gebhardt & Robert C. Shamberger. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood
257
293
.
Rudolf Schwarz, Oyvind Bruland, Anna Cassoni, Paula Schomberg & Stefan Bielack. 2010. Pediatric and Adolescent Osteosarcoma. Pediatric and Adolescent Osteosarcoma
147
164
.
Nancy Gordon & Eugenie S. Kleinerman. 2010. Pediatric and Adolescent Osteosarcoma. Pediatric and Adolescent Osteosarcoma
497
508
.
Irene von Luettichau, Stephan Segerer, Alexandra Wechselberger, Mike Notohamiprodjo, Michaela Nathrath, Markus Kremer, Anna Henger, Roghieh Djafarzadeh, Stefan Burdach, Ralf Huss & Peter J Nelson. (2008) A complex pattern of chemokine receptor expression is seen in osteosarcoma. BMC Cancer 8:1.
Crossref
Crossref
Yi Guo, Elyssa M. Rubin, Jun Xie, Xiaolin Zi & Bang H. Hoang. (2008) Dominant Negative LRP5 Decreases Tumorigenicity and Metastasis of Osteosarcoma in an Animal Model. Clinical Orthopaedics and Related Research 466:9, pages 2039-2045.
Crossref
Crossref
Brent S. Sorenson, Kaysie L. Banton, Natalie L. Frykman, Arnold S. Leonard & Daniel A. Saltzman. (2008) Attenuated Salmonella typhimurium with interleukin 2 gene prevents the establishment of pulmonary metastases in a model of osteosarcoma. Journal of Pediatric Surgery 43:6, pages 1153-1158.
Crossref
Crossref
Brent S. Sorenson, Kaysie L. Banton, Natalie L. Frykman, Arnold S. Leonard & Daniel A. Saltzman. (2008) Attenuated Salmonella typhimurium with IL-2 Gene Reduces Pulmonary Metastases in Murine Osteosarcoma. Clinical Orthopaedics and Related Research 466:6, pages 1285-1291.
Crossref
Crossref
Chigusa Sawamura, Francis J. Hornicek & Mark C. Gebhardt. (2008) Complications and Risk Factors for Failure of Rotationplasty: Review of 25 Patients. Clinical Orthopaedics and Related Research 466:6, pages 1302-1308.
Crossref
Crossref
Pingyu Zhang, Yanwen Yang, Patrick A. Zweidler-McKay & Dennis P.M. Hughes. (2008) Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis. Clinical Cancer Research 14:10, pages 2962-2969.
Crossref
Crossref
Kenshi Sakayama, Naohiko Mashima, Teruki Kidani, Tatsuhiko Miyazaki, Haruyasu Yamamoto & Hiroshi Masuno. (2007) Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a human osteosarcoma cell line. Cancer Chemotherapy and Pharmacology 61:3, pages 471-479.
Crossref
Crossref
Chikako Fukukawa, Hirofumi Hanaoka, Satoshi Nagayama, Tatsuhiko Tsunoda, Junya Toguchida, Keigo Endo, Yusuke Nakamura & Toyomasa Katagiri. (2008) Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Science 99:2, pages 432-440.
Crossref
Crossref
Young-Chae Chang, Won-Hwan Park, Kwan-Sik Min, Teoan Kim, Cheorl-Ho Kim & Jeong Han Kang. (2008) Proteome Profiling of U2OS Cell Line in Response to a Prenylphenol Antibiotic Isolated from a Phytopathogenic Fungus. Biological and Pharmaceutical Bulletin 31:9, pages 1696-1703.
Crossref
Crossref
Michael Daskalakis, Karl Henne, Hartmut Henß, Uwe Martens, Werner Digel, Rupert Engelhardt, Florian Otto, Barbara Deschler, Dietmar P. Berger, H.-P. Allgaier, Jan Harder, D. Behringer, Cornelius Waller, Martin Trepel, Ingo Runnebaum, Christian Weissenberger, Alexandros Spyridonidis, Wolfgang Schultze-Seemann, K.G. Schrenk, Hartmut Neumann, Martin Reincke, Jochen Seufert, Michael Schwabe, Hendrik Veelken, Reinhard Marks, Jürgen Finke, Jürgen Heinz & M. Kleber. 2008. Concise Manual of Hematology and Oncology. Concise Manual of Hematology and Oncology
528
780
.
Rita Turello, Katharina Rentsch, Ermindo Di Paolo & Maja Beck Popovic. (2008) Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism. Pediatric Blood & Cancer 50:1, pages 154-156.
Crossref
Crossref
Dong Wang, Zhao-Yang Zhong, Meng-Xia Li, De-Bing Xiang & Zeng-Peng Li. (2007) Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo. Cancer Science 98:12, pages 1993-2001.
Crossref
Crossref
Nancy Gordon, Nadezhda V. Koshkina, Shu-Fang Jia, Chand Khanna, Arnulfo Mendoza, Laura L. Worth & Eugenie S. Kleinerman. (2007) Corruption of the Fas Pathway Delays the Pulmonary Clearance of Murine Osteosarcoma Cells, Enhances Their Metastatic Potential, and Reduces the Effect of Aerosol Gemcitabine. Clinical Cancer Research 13:15, pages 4503-4510.
Crossref
Crossref
Min Suk Kim, Won Seok Song, Wan Hyeong Cho, Soo-Yong Lee & Dae-Geun Jeon. (2007) Ezrin Expression Predicts Survival in Stage IIB Osteosarcomas. Clinical Orthopaedics & Related Research 459, pages 229-236.
Crossref
Crossref
Jun-qiang YIN, Jing-nan SHEN, Wei-wei SU, Jin WANG, Gang HUANG, Song JIN, Qian-chen GUO, Chang-ye ZOU, Hao-miao LI & Fo-bao LI. (2007) Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines. Acta Pharmacologica Sinica 28:5, pages 712-720.
Crossref
Crossref
M. John Hicks, Jill R. Roth, Claudia A. Kozinetz & Lisa L. Wang. (2007) Clinicopathologic Features of Osteosarcoma in Patients With Rothmund-Thomson Syndrome. Journal of Clinical Oncology 25:4, pages 370-375.
Crossref
Crossref
Huiyun WuNicole E. MuscatoAdriana GonzalezYu Shyr. (2017) An EGFR and AKT Signaling Pathway was Identified with Mediation Model in Osteosarcomas Clinical Study. Biomarker Insights 2, pages 117727190700200.
Crossref
Crossref
Maya KansaraDavid M. Thomas. (2007) Molecular Pathogenesis of Osteosarcoma. DNA and Cell Biology 26:1, pages 1-18.
Crossref
Crossref
Jeong Han Kang, Kwan-Kyu Park, In-Seon Lee, Junji Magae, Kunio Ando, Cheorl-Ho Kim & Young-Chae Chang. (2006) Proteome Analysis of Responses to Ascochlorin in a Human Osteosarcoma Cell Line by 2-D Gel Electrophoresis and MALDI-TOF MS. Journal of Proteome Research 5:10, pages 2620-2631.
Crossref
Crossref
Vladimir V Ternovoi, David T Curiel, Bruce F Smith & Gene P Siegal. (2006) Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma. Laboratory Investigation 86:8, pages 748-766.
Crossref
Crossref
C. Marcela Díaz-Montero, James N. Wygant & Bradley W. McIntyre. (2006) PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation. European Journal of Cancer 42:10, pages 1491-1500.
Crossref
Crossref
Peter Anderson. (2006) Liposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide-containing chemotherapy in osteosarcoma. Future Oncology 2:3, pages 333-343.
Crossref
Crossref
Marika Grönroos, Ming Chen, Timo Jahnukainen, Arrigo Capitanio, Roman I. Aizman & Gianni Celsi. (2006) Methotrexate induces cell swelling and necrosis in renal tubular cells. Pediatric Blood & Cancer 46:5, pages 624-629.
Crossref
Crossref
Dennis P.M. Hughes, Dafydd G. Thomas, Thomas J. Giordano, Kevin T. McDonagh & Laurence H. Baker. (2006) Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition. Pediatric Blood & Cancer 46:5, pages 614-623.
Crossref
Crossref
Jin-Jun Zhu, Fo-Bao Li, Xiao-Feng Zhu & Wei-Ming Liao. (2006) The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells. Life Sciences 78:13, pages 1469-1477.
Crossref
Crossref
G. Huygh, Paul M. J. Clement, H. Dumez, P. Schöffski, H. Wildiers, J. Selleslach, J. M. Jimeno, I. De Wever, R. Sciot, L. Duck & A. T. Van Oosterom. (2006) Ecteinascidin-743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients. Sarcoma 2006, pages 1-11.
Crossref
Crossref
DEAN CHOU & CURTIS A. DICKMAN. 2006. Surgical Anatomy & Techniques to the Spine. Surgical Anatomy & Techniques to the Spine
441
448
.
C Marcela Díaz-Montero & Bradley W McIntyre. (2005) Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents. BMC Cancer 5:1.
Crossref
Crossref
Alexander J. Chou, Pamela R. Merola, Leonard H. Wexler, Richard G. Gorlick, Yatin M. Vyas, John H. Healey, Michael P. LaQuaglia, Andrew G. Huvos & Paul A. Meyers. (2005) Treatment of osteosarcoma at first recurrence after contemporary therapy. Cancer 104:10, pages 2214-2221.
Crossref
Crossref
Hue H. Luu, Lan Zhou, Rex C. Haydon, Andrea T. Deyrup, Anthony G. Montag, Dezheng Huo, Robert Heck, Claus W. Heizmann, Terrance D. Peabody, Michael A. Simon & Tong-Chuan He. (2005) Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Letters 229:1, pages 135-148.
Crossref
Crossref
Peter M. Anderson, Gregory A. Wiseman, Linda Erlandson, Vilmarie Rodriguez, Barbara Trotz, Stephen A. Dubansky & Karen Albritton. (2005) Gemcitabine Radiosensitization after High-Dose Samarium for Osteoblastic Osteosarcoma. Clinical Cancer Research 11:19, pages 6895-6900.
Crossref
Crossref
Satoshi Nagayama, Chikako Fukukawa, Toyomasa Katagiri, Takeshi Okamoto, Tomoki Aoyama, Naoki Oyaizu, Masayuki Imamura, Junya Toguchida & Yusuke Nakamura. (2005) Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas. Oncogene 24:41, pages 6201-6212.
Crossref
Crossref
Lisa L. Wang. (2005) Biology of Osteogenic Sarcoma. The Cancer Journal 11:4, pages 294-305.
Crossref
Crossref
L Eikenes, M Tari, I Tufto, Ø S Bruland & C de Lange Davies. (2005) Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts. British Journal of Cancer 93:1, pages 81-88.
Crossref
Crossref
Shinji Kounami, Keiko Nakayama, Megumi Yoshiyama, Tetsu Yoshimasu, Noriyuki Aoyagi & Norishige Yoshikawa. (2005) Non-myeloablative allogenic peripheral blood stem cell transplantation in a patient with refractory osteosarcoma. Pediatric Transplantation 9:3, pages 342-345.
Crossref
Crossref
James T. Cassidy & Ross E. Petty. 2005. Textbook of Pediatric Rheumatology. Textbook of Pediatric Rheumatology
728
743
.
Philip Lanzkowsky. 2005. Manual of Pediatric Hematology and Oncology. Manual of Pediatric Hematology and Oncology
585
603
.
Sue C. Kaste, T. Liu, C.A. Billups, N.C. Daw, C.B. Pratt & W.H. Meyer. (2004) Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatric Blood & Cancer 43:7, pages 723-728.
Crossref
Crossref
Kenshi Sakayama, Teruki Kidani, Tatsuhiko Miyazaki, Haruo Shirakata, Yoshiyuki Kimura, Junji Kamogawa, Hiroshi Masuno & Haruyasu Yamamoto. (2006) Effect of ketoprofen in topical formulation on vascular endothelial growth factor expression and tumor growth in nude mice with osteosarcoma. Journal of Orthopaedic Research 22:6, pages 1168-1174.
Crossref
Crossref
James S. Meyer & William Mackenzie. (2004) Malignant bone tumors and limb-salvage surgery in children. Pediatric Radiology 34:8, pages 606-613.
Crossref
Crossref
Satoshi Nagayama, Megumi Iiizumi, Toyomasa Katagiri, Junya Toguchida & Yusuke Nakamura. (2004) Identification of PDZK4, a novel human gene with PDZ domains, that is upregulated in synovial sarcomas. Oncogene 23:32, pages 5551-5557.
Crossref
Crossref
Dong Wang, Meihua Luo & Mark R. Kelley. (2004) Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: Enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Molecular Cancer Therapeutics 3:6, pages 679-686.
Crossref
Crossref
Dennis P. M. Hughes, Dafydd G. Thomas, Thomas J. Giordano, Laurence H. Baker & Kevin T. McDonagh. (2004) Cell Surface Expression of Epidermal Growth Factor Receptor and Her-2 with Nuclear Expression of Her-4 in Primary Osteosarcoma. Cancer Research 64:6, pages 2047-2053.
Crossref
Crossref
Hong Zhang, Kyosan Yoshikawa, Katsumi Tamura, Takashi Tomemori, Kenji Sagou, Mei Tian, Susumu Kandatsu, Tadashi Kamada, Hiroshi Tsuji, Tetsuya Suhara, Kazutoshi Suzuki, Shuji Tanada & Hirohiko Tsujii. (2004) [11C]Methionine Positron Emission Tomography and Survival in Patients with Bone and Soft Tissue Sarcomas Treated by Carbon Ion Radiotherapy. Clinical Cancer Research 10:5, pages 1764-1772.
Crossref
Crossref
Erik N Zeegen, Luis A Aponte-Tinao, Francis J Hornicek, Mark C Gebhardt & Henry J Mankin. (2004) Survivorship Analysis of 141 Modular Metallic Endoprostheses at Early Followup. Clinical Orthopaedics and Related Research 420, pages 239-250.
Crossref
Crossref
Displaying 200 of 210 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list